Anatumomab mafenatox

Revision as of 22:09, 8 August 2012 by WikiBot (talk | contribs) (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Anatumomab mafenatox
Monoclonal antibody
Type?
SourceTemplate:Infobox drug/mab source
Identifiers
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).

WikiDoc Resources for Anatumomab mafenatox

Articles

Most recent articles on Anatumomab mafenatox

Most cited articles on Anatumomab mafenatox

Review articles on Anatumomab mafenatox

Articles on Anatumomab mafenatox in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Anatumomab mafenatox

Images of Anatumomab mafenatox

Photos of Anatumomab mafenatox

Podcasts & MP3s on Anatumomab mafenatox

Videos on Anatumomab mafenatox

Evidence Based Medicine

Cochrane Collaboration on Anatumomab mafenatox

Bandolier on Anatumomab mafenatox

TRIP on Anatumomab mafenatox

Clinical Trials

Ongoing Trials on Anatumomab mafenatox at Clinical Trials.gov

Trial results on Anatumomab mafenatox

Clinical Trials on Anatumomab mafenatox at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Anatumomab mafenatox

NICE Guidance on Anatumomab mafenatox

NHS PRODIGY Guidance

FDA on Anatumomab mafenatox

CDC on Anatumomab mafenatox

Books

Books on Anatumomab mafenatox

News

Anatumomab mafenatox in the news

Be alerted to news on Anatumomab mafenatox

News trends on Anatumomab mafenatox

Commentary

Blogs on Anatumomab mafenatox

Definitions

Definitions of Anatumomab mafenatox

Patient Resources / Community

Patient resources on Anatumomab mafenatox

Discussion groups on Anatumomab mafenatox

Patient Handouts on Anatumomab mafenatox

Directions to Hospitals Treating Anatumomab mafenatox

Risk calculators and risk factors for Anatumomab mafenatox

Healthcare Provider Resources

Symptoms of Anatumomab mafenatox

Causes & Risk Factors for Anatumomab mafenatox

Diagnostic studies for Anatumomab mafenatox

Treatment of Anatumomab mafenatox

Continuing Medical Education (CME)

CME Programs on Anatumomab mafenatox

International

Anatumomab mafenatox en Espanol

Anatumomab mafenatox en Francais

Business

Anatumomab mafenatox in the Marketplace

Patents on Anatumomab mafenatox

Experimental / Informatics

List of terms related to Anatumomab mafenatox


Overview

Anatumomab mafenatox is a mouse monoclonal antibody which is used to treat cancers. It has a chelator, mafenatox.



Linked-in.jpg